Cargando…
Long‐term efficacy and safety of dichlorphenamide for treatment of primary periodic paralysis
INTRODUCTION/AIM: Long‐term efficacy and safety of dichlorphenamide (DCP) were characterized in patients with primary periodic paralysis (PPP). METHODS: Patients with PPP in a double‐blind, placebo‐controlled study were randomly assigned to receive DCP 50 mg twice daily or placebo for 9 weeks, follo...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290603/ https://www.ncbi.nlm.nih.gov/pubmed/34129236 http://dx.doi.org/10.1002/mus.27354 |